¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 876¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº 2024-2030³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)7.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á±â±â Æ÷Àå¿¡ ´ëÇÑ ¼ö¿ä´Â º´¿ø¿ë ÀÇ·á±â±â¿Í ÷´Ü ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Æú¸®¿¡Æ¿·», Æú¸®ÇÁ·ÎÇÊ·», Æú¸®Ä«º¸³×ÀÌÆ®¿Í °°Àº ÇÃ¶ó½ºÆ½Àº ÀÇ·á±â±â Á¦Á¶¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. º´¿ø Ä¡·á³ª ÁýÁßÄ¡·á¿¡ ºñÇØ ºñ¿ëÀÌ Àú·ÅÇÏ´Ù´Â ÀÌÀ¯·Î ÀçÅÃÀÇ·á ºÎ¹®ÀÌ ¼ºÀåÇϰí ÀÖÀ¸¸ç, ÀÇ·á±â±â¿Í ¿©·¯ º´¿ø °ü·Ã °Ë»ç¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
º´¿ø Ä¡·á³ª ÁýÁßÄ¡·á¿¡ ºñÇØ ºñ¿ëÀÌ Àú·ÅÇÏ´Ù´Â ÀÌÀ¯·Î ÀçÅÃÀÇ·á ºÐ¾ßÀÇ ¼ºÀåÀº ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±â ¼ö¿ä Áõ°¡´Â º´¿ø¿¡¼ Áø´Ü ¸ñÀûÀ¸·Î ½ÃÇàÇÏ´Â ´Ù¾çÇÑ À¯ÇüÀÇ ÀÇ·á °Ë»ç¿¡ ±âÀÎÇÕ´Ï´Ù.
ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±¹³» ÀÇ·áºñ ÁöÃâÀº °¡±î¿î ¹Ì·¡¿¡ °¡¼Ó鵃 °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¼ö¿ä Áõ°¡´Â Àα¸ °í·ÉÈ(65¼¼ ÀÌ»ó), ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ÀÎÇÁ¶ó °È ¹× ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼À¯·´ °æÁ¦ÀÇ °È´Â ¿¬°£ ¿¹»ê¾È¿¡¼ ÀÇ·áºñ ÁöÃâÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ µ¶ÀÏ, ¿µ±¹, ½º¿þµ§ µî ºÏÀ¯·´ ±¹°¡µéÀÇ ÀÇ·áºñ Áõ°¡°¡ ¿¹»óµÇ¸ç, ÀÌ´Â ÀÇ·á±â±â »ý»ê È®´ë·Î À̾îÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª ·¯½Ã¾Æ, ¿ìÅ©¶óÀ̳ª µî À¯·´ Àüȯ±â °æÁ¦±¹°¡ÀÇ Á¤Ä¡Àû ºÒ¾ÈÀÌ ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Á¦Ç°º°·Î´Â PPSUÀÇ ³»¿¼º°ú ³»ÈÇмºÀ¸·Î ÀÎÇØ Æú¸®Æä´Ò¼³Æù(PPSU) ºÐ¾ß°¡ 2023³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ ÇÃ¶ó½ºÆ½Àº ³ôÀº °µµ¿Í ³»±¸¼ºÀ» °¡Áö°í ÀÖÀ¸¸ç, ÇʼöÀûÀÎ ¼ö¼ú Åø·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÁöÃâ Áõ°¡·Î ÀÎÇØ 2023³â ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Áß±¹, Àεµ, ÀϺ» Á¤ºÎ´Â ¸¸¼ºÁúȯ Áõ°¡¸¦ ¹æÁöÇϰí ÀÇ·á ÀÎÇÁ¶ó¸¦ ¾÷±×·¹À̵åÇϱâ À§ÇØ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. 1Àδç ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÏ¸é¼ ÀÌ Áö¿ªÀÇ ÀÇ·á Çõ¸íÀÇ ¹«´ë°¡ µÇ°í ÀÖ½À´Ï´Ù.
- ±ÔÁ¦´Â ÀÇ·á±â±â »ê¾÷¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î À¯·´°ú ºÏ¹ÌÀÇ ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °íǰÁúÀÇ ¾ÈÀüÇϰí È¿°úÀûÀÎ ÀÇ·á±â±â Á¦°ø¿¡ ´ëÇÑ Á¤ºÎÀÇ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
- ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·áÀÇ µ¿Çâ
- Á¦Á¶¾÷ÀÇ µ¿Çâ
- ±â¼ú °³¿ä
- ÇÃ¶ó½ºÆ½º° ÁÖ¿ä ±¸ÀÔ ±âÁØ
- º¥´õ ¼±Åà ±âÁØÀÇ ºÐ¼®
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¾÷°èÀÇ °úÁ¦
- ¾÷°èÀÇ ±âȸ
- ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå - »ç¾÷ ȯ°æ ºÐ¼®
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- ¾÷°è ºÐ¼® - °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
- µ¿À¯·´ÀÇ ¾÷°èÀÇ ÁöÁ¤ÇÐÀû ¿µÇâÀÇ °³¿ä
- COVID-19°¡ ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦4Àå ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¦Ç°ÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- Á¦Ç°º°, 2018-2030³â
- Æú¸®¿¡Æ¿·»(PE)
- Æú¸®ÇÁ·ÎÇÊ·»(PP)
- Æú¸®Ä«º¸³×ÀÌÆ®(PC)
- LCP(Liquid Crystal Polymer)
- Æú¸®Æä´Ò¼³Æù(PPSU)
- Æú¸®¿¡Æ¿·»À̹Î(PEI)
- Æú¸®¸ÞŸũ¸±»ê ¸ÞÆ¿(PMMA)
- ±âŸ
Á¦5Àå ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ¿ëµµÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- ¿ëµµº°, 2018-2030³â
- ÀÇ·á±â±â Æ÷Àå
- ÀÇ·á ºÎǰ
- Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® Æ÷Àå
- Á¤Çü¿Ü°ú¿ë ¼ÒÇÁÆ® »óǰ
Á¦6Àå ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå : Áö¿ªÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ªÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- ºÏ¹Ì
- ºÏ¹Ì ÈÇÐ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- À¯·´ÀÇ ÈÇÐ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
- µ¶ÀÏ
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ÇÁ¶û½º
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÈÇÐ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
- Áß±¹
- Àεµ
- ÀϺ»
- Áß³²¹Ì
- Áß³²¹ÌÀÇ ÈÇÐ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
- ºê¶óÁú
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÈÇÐ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2018-2030³â
- »ç¿ìµð¾Æ¶óºñ¾Æ
Á¦7Àå ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå - °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷ ºÐ·ù
- ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²/ÁöÀ§ ºÐ¼®, 2023³â
- ±â¾÷ È÷Æ®¸Ê ºÐ¼®
- Àü·« ¸ÅÇÎ
- È®´ë
- ÇÕº´°ú Àμö
- ÆÄÆ®³Ê½Ê°ú Çù¾÷
- »õ·Î¿î ÇÁ·Î¼¼½º °³½Ã
- ¿¬±¸°³¹ß
- ±â¾÷ °³¿ä
- Rochling SE &Co. KG
- Nolato AB
- Saint-Gobain
- SABIC
- Orthoplastics Ltd
- Eastman Chemical Company
- Celanese Corporation
- Dow, Inc.
- Tekni-Plex, Inc.
- Solvay SA
- HMC Polymers Company Limited
- ARAN BIOMEDICAL TEORANTA
- Trelleborg Group
- Avantor, Inc.
- Trinseo
- Evonik Industries AG
KSA 24.01.26
Medical Plastic Market Growth & Trends:
The global medical plastic market size is expected to reach USD 87.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.4% from 2024 to 2030. The demand for medical device packaging is likely due to the increased need for in-house and advanced medical devices. Plastics including polyethylene, polypropylene, and polycarbonate are increasingly being utilized in the medical device manufacturing The growth of the home healthcare sector on account of the low costs involved as compared to hospital care and intensive care contributes to a rise in the demand for medical devices and multiple hospital associated tests as well.
The growth of the home healthcare sector on account of the low costs involved as compared to hospital care and intensive care has resulted in a rise in the demand for medical devices. The increasing demand for medical devices can also be attributed to the various types of medical tests conducted by hospitals for diagnostic purposes.
Healthcare spending in the country is likely to accelerate in the near future owing to the growing awareness about healthcare. The rise in demand is driven by the aging population (65 years of age or above), growing prevalence of chronic diseases, infrastructure enhancements and technological advancements in medical plastics market.
The strengthening of the Western European economies is expected to result in an increased provision of healthcare expenditure in the annual budgetary proposals. Moreover, Northern European economies such as Germany, the UK, and Sweden are projected to exhibit an increase in healthcare expenditure, thereby leading to a growth in the production of medical devices. However, the growth is expected to be supported by political unrest in Europe's transition economies such as Russia and Ukraine.
Medical Plastic Market Report Highlights:
- Based on product, the Polyphenylsulfone (PPSU) segment dominated the market in 2023, due to the heat and chemical resistance of PPSU. These plastics possess high strength and durability, making essential surgical tools.
- Asia Pacific possessed a high market share in 2023, due to increasing healthcare expenditure. However, Governments in China, India and Japan are investing heavily, to prevent rising chronic diseases and upgrading healthcare infrastructures. Per capita healthcare spending is elevating, setting the stage for healthcare revolution in the region.
- Regulations are the key factor influencing the medical device industry, thereby influencing the medical plastics market in Europe and North America. Rising government concerns regarding the offering of high-quality, safe, and effective medical devices are expected to have a negative impact on the market growth over the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot, 2023
- 2.2. Polymer Segment Snapshot, 2023
- 2.3. Application Segment Snapshot, 2023
- 2.4. Competitive Landscape Snapshot
Chapter 3. Medical Plastics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Global Plastic Additives Market Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Raw Material Trends
- 3.3.2. Manufacturing Trends
- 3.4. Technology Overview
- 3.4.1. Manufacturing Technology
- 3.5. Key purchasing criteria, by plastics
- 3.6. Vendor selection criteria analysis
- 3.7. Regulatory Framework
- 3.8. Market Dynamics
- 3.8.1. Market Driver Analysis
- 3.8.2. Market Restraint Analysis
- 3.8.3. Industry Challenges
- 3.8.4. Industry Opportunities
- 3.9. Medical Plastics Market- Business Environment Analysis
- 3.9.1. Industry Analysis- Porter's Five Force Analysis
- 3.9.2. Industry Analysis- Macroeconomic Factors Analysis
- 3.10. East European Geopolitical Implication of the Industry Overview
- 3.11. Impact of COVID-19 on Medical Plastics Market
Chapter 4. Medical Plastics Market: Product Estimates & Trend Analysis
- 4.1. Product Movement Analysis & Market Share, 2023 & 2030
- 4.2. Medical Plastics Market Estimates & Forecast, By product, 2018 to 2030 (Kilotons) (USD Million)
- 4.3. Polyethylene (PE)
- 4.3.1. Medical Plastics Market, Estimation and Forecast, by PE, 2018 - 2030 (Kilotons) (USD Million)
- 4.4. Polypropylene (PP)
- 4.4.1. Medical Plastics Market, Estimation and Forecast, by PP, 2018 - 2030 (Kilotons) (USD Million)
- 4.5. Polycarbonate (PC)
- 4.5.1. Medical Plastics Market, Estimation and Forecast, by PC, 2018 - 2030 (Kilotons) (USD Million)
- 4.6. Liquid Crystal Polymer (LCP)
- 4.6.1. Medical Plastics Market, Estimation and Forecast, by LCP, 2018 - 2030 (Kilotons) (USD Million)
- 4.7. Polyphenylsulfone (PPSU)
- 4.7.1. Medical Plastics Market, Estimation and Forecast, by PPSU, 2018 - 2030 (Kilotons) (USD Million)
- 4.8. Polyethylenimine (PEI)
- 4.8.1. Medical Plastics Market, Estimation and Forecast, by PEI, 2018 - 2030 (Kilotons) (USD Million)
- 4.9. Polymethyl Methacrylate (PMMA)
- 4.9.1. Medical Plastics Market, Estimation and Forecast, by PMMA, 2018 - 2030 (Kilotons) (USD Million)
- 4.10. Others
- 4.10.1. Medical Plastics Market, Estimation and Forecast, by Others, 2018 - 2030 (Kilotons) (USD Million)
Chapter 5. Medical Plastics Market: Application Estimates & Trend Analysis
- 5.1. Application Movement Analysis & Market Share, 2023 & 2030
- 5.2. Medical Plastics Market Estimates & Forecast, By Application, 2018 to 2030 (Kilotons) (USD Million)
- 5.3. MEDICAL DEVICE PACKAGING
- 5.3.1. Medical Plastics Market, Estimation and Forecast, by MEDICAL DEVICE PACKAGING, 2018 - 2030 (Kilotons) (USD Million)
- 5.4. Medical Components
- 5.4.1. Medical Plastics Market, Estimation and Forecast, by Medical Components, 2018 - 2030 (Kilotons) (USD Million)
- 5.5. Orthopedic implant packaging
- 5.5.1. Medical Plastics Market, Estimation and Forecast, by Orthopedic implant packaging, 2018 - 2030 (Kilotons) (USD Million)
- 5.6. Orthopedic Soft Goods
- 5.6.1. Medical Plastics Market, Estimation and Forecast, by orthopedic soft goods, 2018 - 2030 (Kilotons) (USD Million)
Chapter 6. Medical Plastics Market: Regional Estimates & Trend Analysis
- 6.1. Regional Movement Analysis & Market Share, 2023 & 2030
- 6.2. North America
- 6.2.1. North America Chemical Market Estimates & Forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. Key country dynamics
- 6.2.2.2. U.S. Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Key country dynamics
- 6.2.3.2. Canada Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Key country dynamics
- 6.2.4.2. Mexico Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.3. Europe
- 6.3.1. Europe Chemical Market Estimates & Forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.3.2. Germany
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Germany Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.3.3. UK
- 6.3.3.1. Key country dynamics
- 6.3.3.2. UK Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.3.4. Italy
- 6.3.4.1. Key country dynamics
- 6.3.4.2. Italy Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.3.5. France
- 6.3.5.1. Key country dynamics
- 6.3.5.2. France Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Chemical Market Estimates & Forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.4.2. China
- 6.4.2.1. Key country dynamics
- 6.4.2.2. China Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.4.3. India
- 6.4.3.1. Key country dynamics
- 6.4.3.2. India Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.4.4. Japan
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Japan Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.5. Central & South America
- 6.5.1. Central & South America Chemical Market Estimates & Forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Brazil Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.6. Middle East & Africa
- 6.6.1. Middles East & Africa Chemical Market Estimates & Forecast, 2018 - 2030 (Kilotons) (USD Million)
- 6.6.2. Saudi Arabia
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Saudi Arabia Medical Plastics market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
Chapter 7. Medical Plastics Market - Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Market Share/Position Analysis, 2023
- 7.4. Company Heat Map Analysis
- 7.5. Strategy Mapping
- 7.5.1. Expansion
- 7.5.2. Mergers & Acquisition
- 7.5.3. Partnerships & Collaborations
- 7.5.4. New Process Launches
- 7.5.5. Research And Development
- 7.6. Company Profiles
- 7.6.1. Rochling SE & Co. KG
- 7.6.1.1. Participant's overview
- 7.6.1.2. Financial performance
- 7.6.1.3. Process benchmarking
- 7.6.1.4. Recent developments
- 7.6.2. Nolato AB
- 7.6.2.1. Participant's overview
- 7.6.2.2. Financial performance
- 7.6.2.3. Process benchmarking
- 7.6.2.4. Recent developments
- 7.6.3. Saint-Gobain
- 7.6.3.1. Participant's overview
- 7.6.3.2. Financial performance
- 7.6.3.3. Process benchmarking
- 7.6.3.4. Recent developments
- 7.6.4. SABIC
- 7.6.4.1. Participant's overview
- 7.6.4.2. Financial performance
- 7.6.4.3. Process benchmarking
- 7.6.4.4. Recent developments
- 7.6.5. Orthoplastics Ltd
- 7.6.5.1. Participant's overview
- 7.6.5.2. Financial performance
- 7.6.5.3. Process benchmarking
- 7.6.5.4. Recent developments
- 7.6.6. Eastman Chemical Company
- 7.6.6.1. Participant's overview
- 7.6.6.2. Financial performance
- 7.6.6.3. Process benchmarking
- 7.6.6.4. Recent developments
- 7.6.7. Celanese Corporation
- 7.6.7.1. Participant's overview
- 7.6.7.2. Financial performance
- 7.6.7.3. Process benchmarking
- 7.6.7.4. Recent developments
- 7.6.8. Dow, Inc.
- 7.6.8.1. Participant's overview
- 7.6.8.2. Financial performance
- 7.6.8.3. Process benchmarking
- 7.6.8.4. Recent developments
- 7.6.9. Tekni-Plex, Inc.
- 7.6.9.1. Participant's overview
- 7.6.9.2. Financial performance
- 7.6.9.3. Process benchmarking
- 7.6.9.4. Recent developments
- 7.6.10. Solvay S.A.
- 7.6.10.1. Participant's overview
- 7.6.10.2. Financial performance
- 7.6.10.3. Process benchmarking
- 7.6.10.4. Recent developments
- 7.6.11. HMC Polymers Company Limited
- 7.6.11.1. Participant's overview
- 7.6.11.2. Financial performance
- 7.6.11.3. Process benchmarking
- 7.6.11.4. Recent developments
- 7.6.12. ARAN BIOMEDICAL TEORANTA
- 7.6.12.1. Participant's overview
- 7.6.12.2. Financial performance
- 7.6.12.3. Process benchmarking
- 7.6.12.4. Recent developments
- 7.6.13. Trelleborg Group
- 7.6.13.1. Participant's overview
- 7.6.13.2. Financial performance
- 7.6.13.3. Process benchmarking
- 7.6.13.4. Recent developments
- 7.6.14. Avantor, Inc.
- 7.6.14.1. Participant's overview
- 7.6.14.2. Financial performance
- 7.6.14.3. Process benchmarking
- 7.6.14.4. Recent developments
- 7.6.15. Trinseo
- 7.6.15.1. Participant's overview
- 7.6.15.2. Financial performance
- 7.6.15.3. Process benchmarking
- 7.6.15.4. Recent developments
- 7.6.16. Evonik Industries AG
- 7.6.16.1. Participant's overview
- 7.6.16.2. Financial performance
- 7.6.16.3. Process benchmarking
- 7.6.16.4. Recent developments